Literature DB >> 29484513

New Perspectives in Clinical Pharmacokinetics-1: the Importance of Updating the Teaching in Pharmacokinetics that both Clearance and Elimination Rate Constant Approaches Are Mathematically Proven Equally Valid.

Roger Jelliffe1, David Bayard2.   

Abstract

The healing professions have only about four main therapeutic tools at their disposal-surgery, drugs, physical therapy, and psychotherapy. For the general profession of internal medicine, drug therapy is its primary tool. Providing an understanding of the state-of-the-art in therapeutic methods, grounded in solid scientific and mathematical rigor, is therefore of the utmost clinical importance for both physicians and clinical pharmacists. This is particularly true where rapidly evolving scientific changes require an up-to-date education upon which students can rely. Unfortunately, relatively little attention has been paid to training clinical pharmacokineticists and physicians to manage drug therapy optimally for patients under their care in their everyday practice. In this paper, we discuss one of these basic deficiencies from the perspective of the longstanding controversy in pharmacokinetic modeling: whether the volume and clearance approach or the volume and rate constant approach is somehow "better". We examine this controversy using the mathematical principle of invariance, which to our knowledge has not been done before. The conclusion of this analysis is that both approaches are rigorously proven mathematically to be equally valid. We also discuss some implications of these equally valid approaches from the framework of mechanistic and non-compartmental models. Ultimately, the conclusion is that the choice of one parameterization over the other is based on preference or usefulness for research or clinical practice, but no longer, because of this analysis, on science.

Entities:  

Keywords:  clearance; model parameterization; pharmacokinetics; rate constant

Mesh:

Year:  2018        PMID: 29484513     DOI: 10.1208/s12248-018-0185-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  7 in total

1.  A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

Authors:  David S Bayard; Roger W Jelliffe
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

Review 2.  Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.

Authors:  A Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2012-05-30       Impact factor: 6.875

Review 3.  Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini-review on fundamental concepts and applications.

Authors:  Gregory Z Ferl; Frank-Peter Theil; Harvey Wong
Journal:  Biopharm Drug Dispos       Date:  2016-03       Impact factor: 1.627

4.  Interdependency of pharmacokinetic parameters: a chicken-and-egg problem? Not!

Authors:  Reza Mehvar
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

Review 5.  Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors:  Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

6.  Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools.

Authors:  Roger Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

7.  Clearance concepts in pharmacokinetics.

Authors:  M Rowland; L Z Benet; G G Graham
Journal:  J Pharmacokinet Biopharm       Date:  1973-04
  7 in total
  2 in total

Review 1.  How Transporters Have Changed Basic Pharmacokinetic Understanding.

Authors:  Leslie Z Benet; Christine M Bowman; Jasleen K Sodhi
Journal:  AAPS J       Date:  2019-09-03       Impact factor: 4.009

2.  Expert Discussion of the Role of Rate Constant Versus Clearance Approaches to Define Drug Pharmacokinetics: Theoretical and Clinical Considerations.

Authors:  Marilyn N Martinez; Roger W Jelliffe; Johannes H Proost
Journal:  AAPS J       Date:  2020-01-06       Impact factor: 4.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.